CZS-241
Product Specifications
Target
PLK|||Apoptosis|||Others|||Trk receptor
Related Pathways
Others|||Tyrosine Kinase/Adaptors|||Apoptosis|||Cell Cycle/Checkpoint
Bioactivity
CZS-241 is an orally active, selective Polo-like Kinase (PLK) 4 inhibitor with an IC 50 of 2.6 nM that also inhibits TRKA at an IC 50 of 2.74 ?M. It induces apoptosis and causes cell cycle arrest at the S/G2 phase, demonstrating potent antiproliferative effectiveness against leukemia cell lines while maintaining safety towards normal cell lines.
Smiles
CC1=CC(=NN1)NC2=C3C=NN(C3=NC(=N2)NCC4=CC(=C(C=C4)Cl)C(=O)NC5=C(C=CC(=C5)F)F)C(C)C
Molecular Formula
C26H24ClF2N9O
Molecular Weight
551.98
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
sc-286439A 50 mg
N-Omega- (2-Acetamido-3,4,6-tri-O-benzyl-2-deoxy-b-D-glucopyranosyl) -N-a-Boc-L-asparagine benzyl ester
Ask
View Details